Video & Transcript Research : 'FDA'

Page 8 of 62
TX

Texas 89th Regular

Public Health Mar 10th, 2025

Public Health

Transcript Highlights:
  • They already have been approved. by the FDA as a medical food for the treatment of dementia.
  • However, I have to say the FDA doesn't like that.
  • The FDA would have not given this.
  • Personally, the difference between FDA cleared and FDA approved? Really great question.
  • The first one who did it got FDA approval.
Bills: HB5, HJR3, HB155, HB513, HB5, HB155
NH

New Hampshire 2026 Regular Session

House Executive Departments and Administration (04/15/2026)

Executive Departments and Administration

Transcript Highlights:
  • You know, we want to make sure providers can still use FDA-authorized and HIPAA-compliant technologies
  • It's unfortunately the FDA has not weighed in.
  • But on the FDA level, it would be at a claim level.
  • But on the FDA level, it would be at a claim level.
  • digital therapeutics that are FDA digital therapeutics that are FDA related<01:06:44.880> or<
Keywords: 1189, house, all
TX

Texas 89th Regular

Senate Session Apr 29th, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • The FDA recommends the drugs not be purchased online. That's the current FDA recommendation.
  • But that's not happening, nor is the FDA investigating the harm.
  • The FDA report..." "The FDA reports 36 that I'm aware of.
  • And, of course, that's the FDA numbers and other states..."
  • I was talking about the question about whether the FDA numbers are accurate."
Summary: The Senate began with a quorum call, prayer, approval of the previous journal, and messages from the House, then moved through several recognitions and resolutions honoring visiting groups. Members adopted resolutions recognizing the Texas chapters of Blue Star Mothers of America, Fine Arts Education Day, Donate Life Texas Day, Baha’i Capitol Day, County Government Day, Jack County Day, Crockett County Day, and a recognition of Navy Petty Officer Simon Urbanik for service during the Cuban Missile Crisis. The chamber also heard remarks from visiting doctors, students, county officials, and community groups, with multiple senators speaking in support of military families, arts education, organ donation, and local government service. The Senate then took up Committee Substitute Senate Bill 2779, relating to the allocation and use of certain hotel occupancy tax revenues. Senator Birdwell said the bill would stop local governments from conditioning HOT funds on race- or class-based priorities and would require Galveston to transfer the full state rebate for beach cleaning and maintenance to its park board. After questions, the Senate suspended the rules, passed the bill to engrossment, suspended the three-day rule, and finally passed it, though the final vote showed significant opposition. The chamber also passed Committee Substitute Senate Bill 2322, described as a cleanup bill removing the compelling-factor test for dispatchable generation from the Texas Jobs, Energy, Technology, and Innovation Act. A major debate centered on Committee Substitute Senate Bill 2253, which would phase out uncertified teachers in core classrooms and strengthen educator certification requirements. Senator Creighton argued the bill responds to a teacher pipeline crisis, adds parent notification, creates multiple preparation pathways, and provides financial incentives for certification; Senator West and Senator Sparks pressed for rural flexibility and implementation details. An amendment from Senator Gutierrez to add a teacher student-loan repayment program failed on a 11-17 vote, while other technical and fiscal amendments were adopted. The bill then passed to engrossment, the three-day rule was suspended, and it was finally passed. The Senate also passed Committee Substitute Senate Bill 2371, updating skimmer-reporting rules to cover electronic terminals beyond fuel pumps, and Committee Substitute Senate Bill 2351, relating to the construction of certain concrete plants under a standard permit. Senate Bill 619, a conscience-protection bill for health care workers, drew extended questioning from Senators Cook, Eckhardt, and Menendez about patient abandonment, scope, and whether it could allow refusals of legal services such as vaccines, antibiotics, contraception, or personal care; despite those concerns, the Senate suspended the rules and passed the bill to engrossment. Finally, the chamber began consideration of Committee Substitute Senate Bill 1169, which would allow public entities to form public utility agencies to cooperate on water and wastewater projects without eminent domain or cross-collateralization, with Senator Hinojosa explaining it as a tool for small and rural communities facing utility infrastructure problems.
HI
Transcript Highlights:
  • Some of the actors, if some of the actors are violating HR 386 or FDA rules, enforce against them.
  • to want, can easily distinguish one products from registered 503B facilities, which have NDC's and FDA
  • Some of the actors, if some of the actors are violating HR 386 or FDA rules, enforce against them.
  • Some of the actors, if some of the actors are violating HR 386 or FDA rules, enforce against them.
  • Some of the actors, if some of the actors are violating HR 386 or FDA rules, enforce against them.
FL

Florida 2026 Regular Session

Health Policy Feb 11th, 2026

Health Policy

Transcript Highlights:
  • It authorizes podiatric physicians to perform certain non-FDA-approved stem cell therapies within the
  • It requires stem cells to be sourced from FDA-registered and properly accredited facilities.
  • The therapies are not FDA approved. The patients would have to basically acknowledge via signature.
  • The cellular-type therapy, I guess, we're doing, is not FDA approved.
  • So I was just asking for Senator Massullo to just clarify that it is or it isn't FDA approved.
Summary: The committee took up several health-related bills and confirmations. It first heard SB 1414 on congenital cytomegalovirus education, which would require the Department of Health to develop and distribute educational materials to expectant and new parents through maternity, prenatal, newborn, and OB-GYN settings; an amendment removed a section on required instruction for medical professionals, and the bill was reported favorably as a committee substitute. The committee then approved a block of appointees on tabs 2 through 7 and separately confirmed Chavon Harris as Secretary of the Agency for Health Care Administration after her testimony on Medicaid accountability, transparency, managed care oversight, rural health, behavioral health, and the state’s technology modernization efforts. Senators asked Harris about Hope Florida, Medicaid redeterminations, the CORE project, an anti-marijuana ad campaign at DCF, and compliance with a federal Medicaid-related court order; she said she would follow up on some issues. The confirmation was recommended favorably, with Senator Berman voting no. The committee next passed SB 186 on student health and safety, which expands epilepsy and seizure-disorder training requirements to more school personnel, including bus drivers and charter school staff, and requires seizure-first-aid posters and updated Department of Health education efforts. It also approved SB 902 on Department of Health issues after amendments narrowed the bill’s scope and added provisions on medical marijuana regulation, early childhood intervention, practitioner accountability, and autism workforce development; one speaker raised concerns about marijuana dispensary location restrictions and low-THC ratios. SB 196 creating a uterine fibroid research database was also reported favorably after an amendment protecting patient privacy; the bill drew emotional testimony from a patient describing severe symptoms and the need for more research. SB 688 on naturopathic medicine was approved after committee discussion about scope of practice, referral obligations, and whether naturopathic care should be adjunctive to conventional medicine; supporters described complementary care and access issues, while opponents worried about delayed treatment for serious disease. Later, the committee passed SB 1574, “Maddie’s Law,” to add biliary atresia screening to newborn screening using the same blood specimen already collected at birth and to launch an education campaign; parents of a child affected by the disease testified that earlier screening could have prevented severe harm. SB 878 on clinical laboratory personnel was reported favorably to address staffing shortages by allowing Florida to rely more directly on federal CLIA standards for qualified lab workers. SB 1092 on podiatric medicine was approved after an amendment narrowed it to cellular/tissue-based products and podiatrists’ use of certain therapies; the bill also addresses continuing education, informed consent, and advertising disclosures. SB 1032 on medical marijuana was amended and passed, aligning physician certification and card renewal timelines, setting 70-day and 35-day supply limits, and reducing the fee for honorably discharged veterans while preserving funding for FAMU; Senator Harrell opposed it, saying the longer timeframes were too much of an expansion. The committee also heard SB 1760 on Medicaid coverage transparency from Senator Brodeur, who said the bill focuses on accountability and fiscal responsibility, but the transcript cuts off before further discussion or action on that measure.
TX

Texas 89th 2nd C.S.

Licensing & Administrative Procedures Mar 25th, 2025

Licensing & Administrative Procedures

Transcript Highlights:
  • Under current laws, certain FDA regulated medical devices that incorporate boilers are subject to both
  • That are part of FDA regulated medical equipment from additional state boiler registration and inspection
  • House Bill 1888 exempts small boilers and unfired pressure vessels that are a component of FDA regulated
  • The FDA already imposes strict oversight on medical devices requiring state inspections adds an unnecessary
  • miniature boilers contained within medical devices, which are already rigorously regulated by the US FDA
AL

Alabama 2025 Regular Session

Alabama Senate May 6th, 2025

Alabama Senate Floor Meeting

Transcript Highlights:
  • approved and those to where they are FDA approved and those to where they are FDA approved and those
  • products that are FDA approved that DC products that are FDA approved that DC products that are FDA
  • sell those FDA approved.
  • And I think those FDA approved. And I think those FDA approved.
  • Even the FDA and the Fed consumables. Even the FDA and the Fed consumables.
Bills: SB 66, SB 317, SB 393, SB 397, SB 456, SB 614, SB 628, SB 629, SB 636, SB 715, SB 731, SB 801, SB 872, SB 905, SB 986, SB 1012, SB 1013, SB 1015, SB 1032, SB 1113, SB 1181, SB 1212, SB 1241, SB 1250, SB 1278, SB 1285, SB 1376, SB 1444, SB 1449, SB 1524, SB 1525, SB 1528, SB 1556, SB 1588, SB 1660, SB 1704, SB 1708, SB 1802, SB 1833, SB 1844, SB 1854, SB 1863, SB 1957, SB 1959, SB 1965, SB 1999, SB 2035, SB 2056, SB 2082, SB 2119, SB 2138, SB 2165, SB 2199, SB 2201, SB 2203, SB 2245, SB 2284, SB 2419, SB 2422, SB 2452, SB 2487, SB 2523, SB 2529, SB 2533, SB 2541, SB 2586, SB 2595, SB 2605, SB 2615, SB 2675, SB 2690, SB 2717, SB 2753, SB 2778, SB 2835, SB 2841, SB 2891, SB 2929, SB 2933, SB 3016, SB 3039, SB 3044, HB 912, HB 2525, SJR 3, SB 5, SB 29, SB 326, SB 494, SB 530, SB 769, SB 783, SB 963, SB 1238, SB 1271, SB 1786, SB 1967, SB 2312, SB 72, SB 616, SB 1143, SB 1172, SB 1267, SB 1273, SB 1506, SB 1759, SB 2361, SB 1, SB 260, SB 1637, SJR 36, SJR 50, SJR 63, SJR 59, SCR 12, SCR 39, SCR 48, SCR 19, SB 2023, SB 1524, SB 2422, SB 2119, SB 2753, SB 1863, SB 62, SB 666, SB 847, SB 284, SB 854, SB 1073, SB 810, SB 1505, SB 583, SB 507, SB 1434, SB 1376, SB 1772, SB 2016, SB 1163, SB 1122, SB 731, SB 397, SB 508, SB 1436, SB 287, SB 261, SB 1882, SB 393, SB 1791, SB 209, SB 2429, SB 1999, SB 511, SB 2309, SB 510, SB 1085, SB 1975, SB 2717, SB 1262, SB 636, SB 2056, SB 884, SB 517, SB 1200, SB 1845, SB 2681, SB 2199, SB 2458, SB 801, SB 2533, SB 3014, SB 3013, SB 758, SB 1013, SB 2797, SB 2076, SB 2876, SB 2284, SB 2929, SB 2595, SB 715, SB 1640, SB 1241, SB 2538, SB 1449, SB 2529, SB 986, SB 1181, SB 1359, SB 2245, SB 410, SB 1234, SB 456, SB 1012, SB 2926, SB 2138, SB 2615, SB 2972, SB 2841, SB 3016, SB 1856, SB 2035, SB 1528, SB 1373, SB 672, SB 2891, SB 1854, SB 317, SB 2539, SB 2532, SB 1250, SB 2082, SB 2203, SB 1285, SB 1959, SB 1454, SB 2520, SB 2541, SB 1708, SB 1237, SB 1844, SB 1586, SB 3039, SB 2819, SB 66, SB 629, SB 1015, SB 2342, SB 2903, SB 2933, SB 1965, SB 2477, SB 3029, SB 2605, SB 2419, SB 1957, SB 375, SB 250, SB 777, SB 628, SB 2523, SB 2367, SB 2703, SB 2608, SB 2778, SB 3044, SB 2965, SB 2521, SB 865, SB 1032, SB 2165, SB 2501, SB 2675, SB 2452, SB 2835, SB 872, SB 1212, SB 1278, SB 1588, SB 1602, SB 1704, SB 1723, SB 1833, SB 1858, SB 1946, SB 2009, SB 2177, SB 2460, SB 2785, SB 2373, SB 1660, SB 614, SB 867, SB 1608, SB 1525, SB 905, SB 640, SB 2487, SB 1698, SB 383, SB 705, SB 748, SB 1113, SB 1117, SB 1802, SB 2340, SB 2586, SB 2680, SB 2690, SB 2994, SB 2747, SB 1950, SB 913, SB 1071, SB 1086, SB 1087, SB 1483, SB 1444, SB 1553, SB 1556, SB 1703, SB 2133, SB 2297, SB 2298, SB 2622, SB 2955, SB 3059, SB 2782, SB 2781, SB 2637, SB 2633, SB 2337, SB 2334, SB 1861, SB 2043, SB 1367, SB 946, SB 945, SB 2857, SB 128, SB 571, SB 1263, SB 3058, SB 612, SB 2221, SB 2587, SB 2044, SB 2363, SB 2713, HB 1109, HB 1392, HB 22, HB 2525, HB 3093, HB 517, HB 912, HB 1130, HB 142, HB 1689, HB 2018, SB 2311, SB 1986, SB 2565, SB 2943, SB 1888, SB 2417, SB 3048, SB 3052, SB 3053, SB 3036, SB 3057, SB 3056, SB 3043, SB 3037, SB 3050, SB 3063, SB 3047, SB 3035, HJR 98, HJR 99, HB 136, HB 2884, HB 1393, HB 2730, HB 1399, HB 1244, HB 467, HB 331, HB 2559, SB 66, SB 456, SB 628, SB 1012, SB 1015, SB 1032, SB 1241, SB 1376, SB 1708, SB 1959, SB 1965, SB 2035, SB 2199, SB 2245, SB 2284, SB 2419, SB 2523, SB 2529, SB 2541, SB 2595, SB 2605, SB 2778, SB 2933, SB 3039, SB 3044, SB 1524, SB 1863, SB 2119, SB 2422, SB 2753, SB 1844, SB 2533, SR 417, SR 500, SR 501, SR 502, HCR 128, HB 23, HB 45, HB 104, HB 519, HB 748, HB 791, HB 1056, HB 1481, HB 3181, HB 3211, HB 4044, HB 4290, HB 23, HB 45, HB 104, HB 519, HB 748, HB 791, HB 1056, HB 1481, HB 3181, HB 3211, HB 4044, HB 4290
TX

Texas 89th Regular

Senate Session Apr 29th, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • The FDA recommends the drugs not be purchased online.
  • Current FDA recommendations.
  • But I want to stress the FDA does not I'd recommend buying for Preston online.
  • Reported by the FDA the FDA should immediately reinstate earlier strong patient safety protocols to make
  • The FDA reports... 36 that I'm aware of.
Bills: SJR59, SCR30, SCR46, SB31, SB127, SB324, SB401, SB407, SB467, SB482, SB506, SB529, SB584, SB619, SB636, SB646, SB647, SB659, SB715, SB732, SB735, SB771, SB784, SB800, SB801, SB816, SB1013, SB1026, SB1049, SB1055, SB1065, SB1137, SB1169, SB1181, SB1383, SB1395, SB1410, SB1433, SB1524, SB1531, SB1568, SB1640, SB1666, SB1681, SB1718, SB1754, SB1757, SB1972, SB1980, SB2004, SB2007, SB2041, SB2046, SB2050, SB2075, SB2076, SB2154, SB2173, SB2206, SB2225, SB2253, SB2268, SB2306, SB2308, SB2314, SB2322, SB2330, SB2351, SB2366, SB2371, SB2392, SB2398, SB2476, SB2533, SB2540, SB2544, SB2589, SB2610, SB2623, SB2660, SB2662, SB2693, SB2707, SB2717, SB2722, SB2742, SB2753, SB2779, SB2807, SB2843, SB2844, SB2858, SB2877, SB2880, SB2885, SB2920, SB2938, SB2986, HJR4, HCR35, SJR3, SJR18, SB5, SB260, SB1786, SB914, SB963, SB1197, SB1415, SB1437, SJR36, SJR50, SJR63, SJR84, SJR59, SCR12, SCR39, SCR46, SCR48, SCR19, SCR30, SCR3, SB2023, SB1433, SB2322, SB2877, SB407, SB1718, SB1395, SB62, SB666, SB847, SB284, SB854, SB1073, SB810, SB1505, SB583, SB1502, SB507, SB1026, SB1434, SB1376, SB1585, SB1772, SB2016, SB1163, SB619, SB1122, SB732, SB731, SB397, SB508, SB1436, SB287, SB261, SB1882, SB393, SB1791, SB529, SB209, SB2429, SB1999, SB511, SB2309, SB510, SB2253, SB584, SB1085, SB2314, SB2046, SB1975, SB2717, SB1262, SB1524, SB1137, SB636, SB2056, SB884, SB517, SB1200, SB1410, SB1845, SB1863, SB2681, SB2200, SB2199, SB1757, SB2050, SB2458, SB2201, SB1055, SB2660, SB2662, SB1065, SB801, SB2533, SB3014, SB3013, SB758, SB647, SB1721, SB2268, SB2366, SB1013, SB2797, SB2371, SB2383, SB646, SB1169, SB1754, SB2779, SB2004, SB2119, SB2448, SB1777, SB1283, SB2392, SB2076, SB2786, SB2876, SB2284, SB2225, SB1540, SB2920, SB2929, SB1972, SB2540, SB2742, SB2595, SB2217, SB715, SB2330, SB1383, SB500, SB1640, SB2001, SB2080, SB2722, SB506, SB2514, SB2623, SB2753, SB2398, SB1241, SB2927, SB2173, SB2538, SB898, SB467, SB1449, SB2529, SB1531, SB2846, SB2476, SB986, SB1181, SB2075, SB2154, SB2864, SB31, SB2880, SB1359, SB2386, SB771, SB2844, SB2550, SB1351, SB1423, SB1931, SB2245, SB2589, SB2707, SB2807, SB2351, SB410, SB659, SB816, SB2776, SB2693, SB2580, SB1980, SB1886, SB1234, SB739, SB482, SB456, SB127, SB1666, SB2843, SB2801, SB800, SB2055, SB784, SB2986, SB735, SB1012, SB324, SB2926, SB2938, SB2007, SB2138, SB1242, SB2615, SB1049, SB2310, SB1224, SB2972, SB1568, SB2841, SB2885, SB3016, SB2858, SB2610, SB2139, SB1856, SB2035, SB2308, SB2306, SB2041, SB1528, SB1681, SB1141, SB2401, SB2530, SB2375, SB547, SB1266, SB1373, SB1467, SB2069, SB2269, SB2480, SB2544, SB672, SB904, SB2695, SB2891, SB2422, SB2543, SB1854, SB317, SB2539, SB2532, SB2925, SB1250, SB2082, SB2203, SB457, SB2357, HJR4, HB135, HB1109, HCR35, HCR64, SB2721, SB243, SB1285, SB2568, SB1959, SB1442, SB1454, SB2520, SB2541, SB1708, SB1237, SB1844, SB1586
TX

Texas 89th Regular

Insurance Apr 23rd, 2025

Insurance

Transcript Highlights:
  • FDA doesn't require that monitoring to occur in a hospital.
  • FDA protocols.
  • We need to ensure that qualified community cancer centers operating under FDA-approved guidelines can
  • Center offered FDA-approved CAR-T therapy, and Thomas was a recipient in late November of 2024.
  • cell transplant products because the manufacturing of CAR T-cell therapy products is extensively FDA
FL
Transcript Highlights:
  • Does that include notification that what they are receiving is not FDA approved? Senator Trumbull.
  • How will the state monitor the outcomes and the safety for patients who receive this non-FDA-approved
  • getting an unregulated treatment versus a regulated therapy, a therapy that's been approved by the FDA
  • little tighter language as it moves forward in what that specifically says, that not only it is not FDA
  • I do need to clarify that currently the stem cells are FDA approved.
Summary: The committee met to consider a large agenda of health and human services bills, moving quickly because of a two-hour time limit. Early measures reported favorably included SB 976 on challenges to court-appointed psychologists in family law cases, SB 306 on Medicaid provider network access and after-hours availability, and SB 584 on housing supports for college students and youth in extended foster care. SB 1412 on home health regulation modernization also passed, with one support appearance from the Home Care Association. Members then approved several bills focused on research and care delivery, including SB 1800 creating a Parkinson’s disease research consortium at USF with an adopted amendment adding academic medical centers, SB 524 adding Duchenne muscular dystrophy to newborn screening, SB 1156 revising a Medicaid home health aide program for medically fragile children, and SB 1490 transferring and redesigning the managed care program for critically ill children. SB 1174 on foster home licensure transfers, SB 1620 implementing mental health and substance use commission recommendations, SB 1568 revising e-prescribing exemptions, and SB 788 on veterans nursing home beds were also reported favorably. The committee had more extensive debate on SB 1270, the Department of Health agency package, which included provisions on vaccination status, medical marijuana background screening, licensing and compact issues, and sovereign immunity for volunteer dental workers; it passed after an amendment and several members voiced concerns about patient treatment and “voting power” language. SB 1606 on patient access to records drew strong opposition from providers and health information professionals over privacy, HIPAA, and administrative burdens; it was initially reported unfavorably, then reconsidered and ultimately passed after a motion to reconsider. Other bills reported favorably included SB 1736 on insulin administration by direct support professionals and relatives, SB 1808 on patient refunds from providers, SB 1842 on referral disclosure of network status, SB 1354 on behavioral health managing entity oversight, SB 1768 on stem cell therapies with informed consent requirements, and SPB 7032 on presumptive Medicaid eligibility for permanently disabled individuals, which was submitted and reported as a committee bill. The meeting ended after all agenda items were handled and the committee adjourned.
FL

Florida 2026 Regular Session

Appropriations Committee on Health and Human Services Feb 18th, 2026

Appropriations Committee on Health and Human Services

Transcript Highlights:
  • The FDA currently requires human cell and tissue-type cells under 21 CFR 1271 federal guidelines, focusing
  • It refines the scope of practice by permitting podiatric physicians to use certain non-FDA-approved cellular
  • notice and informed consent requirements, including explicit disclosure that certain products are not FDA
  • And just for clarification, although the stem cells are not FDA approved for that particular thing, this
  • The bill authorizes a registered nurse to delegate the administration of an FDA-approved and prescribed
Summary: The Appropriations Committee on Health and Human Services met to hear and vote on a series of health, human services, and education-related bills, along with a presentation of the committee’s proposed HHS budget. The budget was described as increasing by more than $2.1 billion over the current base, with major funding highlighted for Medicaid and KidCare, rural health, provider rate increases, child welfare, mental health and substance use, opioid treatment, Alzheimer’s initiatives, cancer research, ADAP, veterans’ services, and IT modernization. Public testimony on the budget focused heavily on AIDS Drug Assistance Program funding and concerns about Department of Health changes affecting access, premium assistance, notice, and continuity of care for people living with HIV/AIDS. Among the bills reported favorably were measures on podiatric medicine and tissue-based products (SB 1092), background screening and clearinghouse procedures (SB 1168), child protective investigations involving specific medical diagnoses and second opinions (SB 42), clinical laboratory personnel licensure standards (SB 878), uterine fibroid data tracking and research (SB 196), medical marijuana treatment center oversight and related health provisions (SB 902), dyslexia and dyscalculia screening and intervention in schools (SB 1340), memory care licensure for assisted living facilities (SB 1404), congenital CMV education materials (SB 1414), Parkinson’s disease registry and related public records exemption bills (SB 1684 and SB 1686), and occupational therapy dry needling licensure standards (SB 914). Several bills were amended before passage, including SB 1092, SB 42, SB 902, SB 1684, and SB 1404. Testimony generally came from professional associations, advocacy groups, and affected stakeholders, with support voiced for most measures. The committee adopted amendments on the floor, heard no opposition during debate on the bills described, and then voted to report each measure favorably. At the end of the meeting, senators requested to be recorded in the affirmative on selected bills, and the committee adjourned.
CO

Colorado 2026 Regular Session

Colorado House 2026 Legislative Day 101 Apr 24th, 2026

Colorado House Floor Meeting

Transcript Highlights:
  • to the FDA.
  • to the FDA.
  • to the FDA.
  • to the FDA.
  • <03:21:42.160> FDA on the FDA approved drug label. FDA on the FDA approved drug label.
Keywords: 981, all
Summary: The House convened with a quorum, approved the journal from April 23, and then moved through announcements and recognitions before taking up third-reading business. Members recognized a guest connected to the Mason Museum and Learning Center in Aurora, honored the family of a bicyclist killed in a 2021 hit-and-run, and heard reminders about open enrollment and an upcoming Auctioneer Day fundraiser for nonpartisan staff. The chamber also welcomed guests from Concerned Women for America and celebrated a pair of birthdays with the capital choir. On legislation, Senate Bill 95, concerning measures to support victim survivors of certain crimes without changing substantive criminal offenses, passed third reading 58-0 with five excused. House Bill 1132, which would increase pollinator habitats through conservation of native plant materials on state lands, passed 43-18 with four excused. House Bill 1130, requiring baby diaper changing stations in public restrooms, drew extensive debate: supporters said it would improve accessibility for parents and that small businesses were exempted or given flexibility, while opponents argued it was an unfunded mandate that would burden small businesses, raise installation and liability costs, and create safety and maintenance concerns. The bill ultimately passed 35-28 with two excused. The chamber also passed Senate Bill 136, requiring reporting of missing livestock to the Department of Agriculture, by a vote of 63-0 with two excused, and House Bill 1287, continuing certain Division of Real Estate regulatory functions under the sunset process, by a vote of 49-14 with two excused. Senate Bill 43 was laid over until Monday. At the end of the excerpt, the House began receiving committee reports from Appropriations, listing several bills recommended for referral onward.
MN

Minnesota 2025-2026 Regular Session

Committee on State and Local Government - 03/12/26

State and Local Government

Transcript Highlights:
  • don't like the results of an election and we've all learned that we couldn't trust anything in the FDA
  • don't like the results of an election and we've all learned that we couldn't trust anything in the FDA
  • don't like the results of an election and we've all learned that we couldn't trust anything in the FDA
  • don't like the results of an election and we've all learned that we couldn't trust anything in the FDA
  • don't like the results of an election and we've all learned that we couldn't trust anything in the FDA
Keywords: 1187, senate, all
AZ

Arizona 2026 Regular Session

02/04/2026 - House Judiciary

Judiciary

Transcript Highlights:
  • Kratom is distinctly different, and that's why the FDA Commissioner has made that distinction in the
  • Chairman, Representative Carteros, the FDA has taken a huge pivot on this very issue about the safety
  • And 7-OH is the focus of Commissioner McCarrie at the FDA. HHS Secretary Kennedy.
  • And 7-OH is the focus of Commissioner McCarrie at the FDA. HHS Secretary Kennedy.
  • And the FDA has evaluated that science.
Summary: The committee first heard HB 2415, which would tighten Arizona’s regulation of kratom by treating synthetic or highly concentrated 7-OH products as narcotic drugs, raising the legal sale age to 21, and imposing criminal penalties for prohibited sales or preparation. Supporters, including the sponsor, a recovering user, the American Kratom Association, and the Attorney General’s Office, argued the bill targets dangerous synthetic products while preserving natural kratom leaf products. Opponents, including the Arizona Attorneys for Criminal Justice, warned the amendment could sweep in users and create harsh felony penalties for possession. The committee adopted the Wynn amendment and then gave HB 2415 as amended a 6-3 do-pass recommendation. The committee then considered HB 2870, which would bar multiple Level 2 or Level 3 registered sex offenders from living together in the same residence unless they are related by blood, marriage, or adoption. The sponsor and neighborhood witnesses described a local home with six or seven offenders and said the arrangement frightened nearby families and children. Opponents argued the bill would destabilize housing for people on probation, increase homelessness, and interfere with supervision and rehabilitation; some also noted existing probation oversight and low sexual recidivism rates. After debate over whether the bill should instead target only certain housing settings, the committee voted 5-4 to give HB 2870 a do-pass recommendation. Next, HB 2413 was heard, requiring GPS or electronic monitoring for registered sex offenders who do not have a fixed address until one is established. Supporters said the bill would close a gap for homeless or transient registrants who otherwise report only every 90 days, while opponents raised due process, cost, and implementation concerns, noting that some offenders are already monitored through probation and that DPS does not itself supervise offenders. The committee passed HB 2413 on a 5-4 vote. The committee also heard HB 2720, which increases the penalty for purchasing prostitution to a class 6 felony and directs a $200 assessment to the anti-human trafficking fund. Supporters said it targets buyers and helps deter trafficking demand; opponents argued the bill could still ensnare trafficking victims and sex workers. The committee adopted a Bliss amendment clarifying the affirmative defense and use of funds, then approved HB 2720 as amended by an 8-0 vote with one member present. Finally, HB 2418, appropriating $600,000 from the General Fund to the Arizona Criminal Justice Commission for five major incident division task forces, was supported by county sheriffs’ representatives and passed unanimously by the committee.
PA

Pennsylvania 2025-2026 Regular Session

Senate Session (Jun 24 2026)

Pennsylvania Senate Floor Meeting

Transcript Highlights:
  • current law, a pharmaceutical or medical device manufacturer must first complete the lengthy federal FDA
  • It does not bypass the FDA approval process.
  • It does not allow unapproved products to enter the market and keeps the FDA as the gatekeeper for safety
  • Under current law, a pharmaceutical manufacturer must complete the full federal FDA approval process
  • This bill does not touch federal safety standards, nor does it impact FDA oversight.
Summary: The Senate convened with prayer and the Pledge of Allegiance, received committee reports, and approved the prior day’s journal by a 50-0 vote. Several members were granted leaves of absence, and the chamber also took up a number of procedural motions, including re-referring Senate Bill 1212 to Appropriations and moving Senate Bill 911 from the table to the calendar. The Senate later recessed for committee meetings and party caucuses, then reconvened to continue floor action. On the calendar, Senate Bill 1206 passed 50-0 after supporters said it would help Pennsylvania’s life sciences industry by allowing manufacturers to pursue state licensure while federal FDA approval is pending, without weakening safety standards. Senate Bill 1273 passed 48-2; its sponsor said it would clarify that turnpike automated plate-reading data may be shared with investigators in missing or endangered persons cases, including Amber Alerts. Several other bills were either agreed to and re-referred to Appropriations or ordered over in their place, including House Bill 681, Senate Bills 1061, 1303, and 1355, and House Bill 1505 and 1667. The Senate also considered Senate Resolution 326, where an amendment by Senator Mastriano was adopted and the resolution was then held over as amended. In executive session, the chamber returned several nominations to the governor, then confirmed a slate of gubernatorial nominations, including appointments to the Pennsylvania Drug, Device, and Cosmetic Board, the State Board of Osteopathic Medicine, and several Pennsylvania Army National Guard promotions, by a 50-0 vote. The Senate additionally approved committee-reported bills from Appropriations and Health and Human Services, and signed House Bill 1344 in the presence of the Senate. During petitions and remonstrances, Senator Tartaglione urged action on minimum wage legislation, noting Pennsylvania has not raised the wage since 2006 and pointing to House Bill 2189. Senator Dush delivered extended remarks on the nation’s founding and the religious views of Benjamin Franklin. The Senate then adopted a motion to recess until June 25, 2026, at 9:30 a.m., unless recalled sooner.
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Public Health Jun 21st, 2026 at 01:00 pm

Joint Committee on Public Health

Transcript Highlights:
  • Additionally, today, there is an incredibly effective FDA-approved treatment that I'm here...
  • FDA approved treatments for GOSHA disease. The test is already being done in Massachusetts.
  • But according to the FDA in September 2024, teen vaping had reached a 10-year low.
  • I want to provide some context to FDA statistics that we heard earlier.
  • The truth is, the FDA has not approved this as a harm reduction tool.
Keywords: 995, all
Summary: The Joint Committee on Public Health heard testimony on a wide range of bills focused on children’s health, tobacco control, newborn screening, pediatric cancer, palliative care, and professional licensure. Early testimony highlighted Senate bills to expand newborn screening for pyruvate dehydrogenase complex deficiency, lysosomal storage disorders, and congenital CMV, with families and clinicians describing severe diagnostic delays, missed treatment windows, and the benefits of early detection. Speakers also supported a bill to improve pediatric cancer research through a dedicated trust fund, and a bill to extend pediatric palliative care services to age 22, with parents and providers emphasizing continuity of care for seriously ill young people. Several witnesses gave personal accounts in support of the newborn screening measures. Families described children who endured years of misdiagnosis before receiving diagnoses such as Gaucher disease, Fabry disease, Pompe disease, Niemann-Pick disease, and CMV, often after irreversible damage had already occurred. Medical and advocacy witnesses said Massachusetts already collects some of the relevant screening data and argued that results should be reported to families, while others urged the committee to add conditions to the state panel because effective treatments already exist. The committee also heard support for a bill to establish a fetal alcohol spectrum disorder program and training for providers. On tobacco and youth health, testimony supported bills to ban internet tobacco sales, strengthen youth protections, and reduce lung cancer deaths through point-of-sale information and quit-line access. A student testified about easily purchasing flavored nicotine products online without meaningful age verification, and public health advocates backed measures to keep tobacco out of children’s environments. The committee also heard testimony on a bill to ensure parents have access to their children’s medical records through age 16, with exceptions for sensitive services already protected by law. The committee additionally took testimony on an optometry licensure bill, where ophthalmologists opposed language they said could broaden scope of practice and allow optometrists to use the title “optometric physician,” while optometry educators and students supported the bill as a modernization measure with no scope expansion. No votes were taken during the hearing; the chair repeatedly reminded speakers of time limits and noted that written testimony could be submitted for additional comments.
CA

California 2025-2026 Regular Session

Assembly Judiciary Committee Apr 22nd, 2025

Transcript Highlights:
  • So the FDA has ignored a large and growing body of science that...
  • FDA currently suggests is our exposure level.
  • And we just need to act where the FDA has fallen down on the job. Okay. Thank you.
  • And we just need to act where the FDA has fallen down on the job. Okay, thank you.
  • And we just need to act where the FDA has fallen down on the job. Okay.
Summary: The committee heard several bills, beginning with AB 1521, the Judiciary Committee’s civil law omnibus measure. The bill makes a number of minor, mostly clarifying changes, including repealing obsolete Government Code provisions, allowing juvenile courts to hear petitions to establish records of birth, death, or marriage, requiring notice of probate petitions to the Department of Child Support Services, and correcting typos in existing law. It had no opposition and was moved on a do-pass basis to Appropriations, though it was later placed on call pending additional votes. Members then heard AB 57, which would reserve at least 10% of California’s Home Purchase Assistance Program funds for descendants of formerly enslaved people. The author and supporters framed it as a reparative, race-neutral-by-lineage effort to address historic housing discrimination and the racial wealth gap, while opponents argued it was an unconstitutional racial proxy and should instead be based on individual injury. The bill drew strong support and opposition testimony, was amended, and was approved on a do-pass as amended vote to Appropriations, then placed on call. AB 495, the Family Preparedness Plan Act, was heard next. The bill would expand and standardize caregiving and guardianship tools for families facing immigration-related separation, including broader use of caregiver authorization affidavits, recognition of non-relative extended family caregivers, and a new short-term guardianship process that preserves parental rights. Supporters said it would reduce trauma and help children remain with trusted caregivers; there was no opposition testimony. The committee approved it on a do-pass to Human Services vote and placed it on call. The committee also heard AB 392, which would address non-consensual sharing of sexually explicit media by requiring uploader consent certifications, faster takedown procedures, and civil remedies against uploaders and hosting sites. A survivor testified in support, and members discussed implementation details and possible amendments; the bill was moved on a do-pass as amended basis to Appropriations and placed on call. AB 692, which would prohibit employer “stay-or-pay” debt agreements that require workers to repay training or other costs if they leave or are terminated, also advanced despite opposition from business and industry groups concerned about impacts on signing bonuses and voluntary training programs. It was sent to Appropriations on a do-pass as amended vote and placed on call, along with AB 1234, a wage-claim enforcement bill aimed at reducing Labor Commissioner delays and adding consequences for employers who fail to participate in the process. The committee also heard AB 394, which expands protections for transit workers and allows transit agencies to seek restraining orders against violent riders; it received broad support, some concern about system-wide bans, and was discussed with amendments that preserved judicial discretion.